A Phase 1 Study of Navlimetostat Tablet Formulations

Part of paid clinical trials in Decatur, Georgia.

Sponsor
Bristol-Myers Squibb
Study ID
NCT07544628
Phase
PHASE1
Status
Recruiting
Apply to this trial

Conditions

  • Healthy Participants

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 55 Years
Healthy Volunteers
Accepted

Interventions

Study Details

This study aims to compare the PK of Navlimetostat after administration of a wet-granulation tablet versus the dry-granulation tablet formulation in healthy adult female

Key Dates

Start date
Apr 27, 2026
Status verified
May 2026
Primary completion
Aug 31, 2026
Completion
Oct 15, 2026

Study Design

Enrollment
64 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT

Arms

  • Experimental: Treatment A
  • Experimental: Treatment B

Primary Outcome Measure

Maximum Plasma Concentration (Cmax) [ Time Frame: Up to Day 17 ]

Central Contacts

  • BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
    855-907-3286
    [email protected]
  • First line of the email MUST contain NCT # and Site #.

Locations (3)

FacilityCityStateZIPSite coordinators
CenExel iResearch - DecaturDecaturGeorgia30030
Kimball Johnson, Site 0002
404-537-1281
Local Institution - 0003DecaturGeorgia30030
Site 0003
PPDAustinTexas78744
Sabrina Merchant, Site 0001

Find similar trials in Decatur, GA

By research site
CenExel iResearch - Decatur· Decatur, GALocal Institution - 0003· Decatur, GAPPD· Austin, TX

Related Studies